News
-
-
PRESS RELEASE
Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Onco-Innovations appoints Dr. Islam Mohamed as CMO and Stephen M. Novak as Chief of R&D, aiming to enhance clinical and development capabilities for advancing ONC010. Strategic leadership additions for Onco's transition to clinical-stage execution -
-
PRESS RELEASE
Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy
Onco-Innovations announces engagement with RDI Partners & formation of ONCO AU subsidiary in Australia to support Phase I development activities & potential eligibility for Australia's R&D Tax Incentive program -
-
-
-
-
-
PRESS RELEASE
Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Onco-Innovations Limited announces filing of preliminary base shelf prospectus with securities regulatory authorities in several provinces for potential future offerings. Company focuses on cancer research and treatment